Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variation at NNRTI resistance-associated positions in patients infected with HIV-1 subtype C.

AIDS (London, England) - 9 Apr 2004

Grossman Zehava, Istomin Valery, Averbuch Diana, Lorber Margalit, Risenberg Klaris, Levi Itzchak, Chowers Michael, Burke Michael, Bar Yaacov Nimrod, Schapiro Jonathan M

Abstract excerpt

OBJECTIVE: Genetic differences between subtypes of HIV-1, even when not associated with key resistance mutations, are known to affect baseline susceptibility to specific antiretroviral drugs and resistance-development pathways. We studied the prevalence and patterns of non-nucleoside reverse tran...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkynes
Share to Benzoxazines
Share to Cyclopropanes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Nevirapine

Share to Nucleosides

Share to Oxazines

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 15060438
DOI: 10.1097/00002030-200404090-00008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15060438-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variation at NNRTI resistance-associated positions in patients infected with HIV-1 subtype C.PMID 15060438Read ↗

Impact of Drug Resistance-Associated Amino Acid Changes in HIV-1 Subtype C on Susceptibility to Newer Nonnucleoside Reverse Transcriptase InhibitorsSemantic proximity Read ↗

Nucleotide and amino acid polymorphisms at drug resistance sites in non-B-subtype variants of human immunodeficiency virus type 1.Semantic proximity Read ↗

HIV-1 subtypes: epidemiology and significance for HIV managementSemantic proximity Read ↗

Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir.Semantic proximity Read ↗

Resistance-associated mutation prevalence according to subtypes B and non-B of HIV type 1 in antiretroviral-experienced patients in Minas Gerais, Brazil.Semantic proximity Read ↗

Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence.Semantic proximity Read ↗

Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G.Semantic proximity Read ↗

Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors.Semantic proximity Read ↗

Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG.Semantic proximity Read ↗

Distinct drug resistance profile of HIV-1 subtype A strain circulating in Georgia.Semantic proximity Read ↗

E138A in HIV-1 reverse transcriptase is more common in subtype C than B: Implications for rilpivirine use in resource-limited settingsSemantic proximity Read ↗

Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 Infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.